The association between influenza vaccination and the perception of COVID-19 as well as COVID-19 vaccination behavior among community residents in Anhui province, China

References

• World Health Organization. Influenza seasonal. Published 2023 [accessed 2023 Aug 19]. https://www.who.int/health-topics/influenza-seasonal#tab=tab_1.
   Google Scholar
• Paget J, Spreeuwenberg P, Charu V, Taylor RJ, Iuliano AD, Bresee J, Simonsen L, Viboud C. Global mortality associated with seasonal influenza epidemics: new burden estimates and predictors from the GLaMOR project. J Glob Health. 2019;9(2):020421. doi:10.7189/jogh.09.020421.
   PubMed Web of Science ®Google Scholar
• World Health Organization. GISRS laid the foundation for protection through collaboration. Published 2022 [accessed 2023 Mar 26]. https://www.who.int/news/item/29-07-2022-gisrs-laid-the-foundation-for-protection-through-collaboration.
   Google Scholar
• Li J, Zhang Y, Zhang X, Liu L. Influenza and universal vaccine research in China. Viruses. 2022;15(1):116. doi:10.3390/v15010116.
   PubMed Web of Science ®Google Scholar
• Davis TC, Vanchiere JA, Sewell MR, Davis AB, Wolf MS, Arnold CL. Influenza and COVID-19 vaccine concerns and uptake among patients cared for in a safety-net health system. J Prim Care Community Health. 2022;13:21501319221136361. doi:10.1177/21501319221136361.
   Web of Science ®Google Scholar
• Loeb M, Roy A, Dokainish H, Dans A, Palileo-Villanueva LM, Karaye K, Zhu J, Liang Y, Goma F, Damasceno A, et al. Influenza vaccine to reduce adverse vascular events in patients with heart failure: a multinational randomised, double-blind, placebo-controlled trial [published correction appears in Lancet Glob Health. 2022 Nov 30]. Lancet Glob Health. 2022;10(12):e1835–9. doi:10.1016/S2214-109X(22)00432-6.
   PubMed Web of Science ®Google Scholar
• Hou Z, Guo J, Lai X, Zhang H, Wang J, Hu S, Du F, Francis MR, Fang H. Influenza vaccination hesitancy and its determinants among elderly in China: a national cross-sectional study. Vaccine. 2022;40(33):4806–15. doi:10.1016/j.vaccine.2022.06.063.
   PubMed Web of Science ®Google Scholar
• Zhou S, Greene CM, Song Y, Zhang R, Rodewald LE, Feng L, Millman AJ. Review of the status and challenges associated with increasing influenza vaccination coverage among pregnant women in China. Hum Vaccin Immunother. 2020;16(3):602–11. doi:10.1080/21645515.2019.1664230.
   PubMed Web of Science ®Google Scholar
• Jiang M, Li P, Yao X, Hayat K, Gong Y, Zhu S, Peng J, Shi X, Pu Z, Huang Y, et al. Preference of influenza vaccination among the elderly population in Shaanxi province, China. Hum Vaccin Immunother. 2021;17(9):3119–25. doi:10.1080/21645515.2021.1913029.
   PubMed Web of Science ®Google Scholar
• Yao KH. Some thoughts on influenza vaccine and regular influenza vaccination for healthcare workers. Zhongguo Dang Dai Er Ke Za Zhi (In Chinese). 2018;20(11):881–6. doi:10.7499/j.issn.1008-8830.2018.11.001.
   PubMedGoogle Scholar
• Chen C, Liu X, Yan D, Zhou Y, Ding C, Chen L, Lan L, Huang C, Jiang D, Zhang X, et al. Global influenza vaccination rates and factors associated with influenza vaccination. Int J Infect Dis. 2022;125:153–63. doi:10.1016/j.ijid.2022.10.038.
   PubMed Web of Science ®Google Scholar
• Fan J, Ye C, Wang Y, Qi H, Li D, Mao J, Xu H, Shi X, Zhu W, Zhou Y. Parental seasonal influenza vaccine hesitancy and associated factors in Shanghai, China, during the COVID-19 pandemic: a cross-sectional study. Vaccines (Basel). 2022;10(12):2109. Published 2022 Dec 9. doi:10.3390/vaccines10122109.
   PubMed Web of Science ®Google Scholar
• Yu M, Yao X, Liu G, Wu J, Lv M, Pang Y, Xie Z, Huang Y. Barriers and facilitators to uptake and promotion of influenza vaccination among health care workers in the community in Beijing, China: a qualitative study. Vaccine. 2022;40(14):2202–8. doi:10.1016/j.vaccine.2022.02.060.
   PubMed Web of Science ®Google Scholar
• National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) on Influenza Vaccination. Technical guidelines for seasonal influenza vaccination in China (2022-2023). Zhonghua Yu Fang Yi Xue Za Zhi. 2022;56(10):1356–86. doi:10.3760/cma.j.cn112150-20220825-00840.
   PubMedGoogle Scholar
• Jiang X, Shang X, Lin J, Zhao Y, Wang W, Qiu Y. Impacts of free vaccination policy and associated factors on influenza vaccination behavior of the elderly in China: a quasi-experimental study. Vaccine. 2021;39(5):846–52. doi:10.1016/j.vaccine.2020.12.040.
   PubMed Web of Science ®Google Scholar
• Zhou Y, He X, Li S, Bechir CM. Research on the coordination of fiscal structure and high-quality economic development: an empirical analysis with the example of Anhui province in China. PloS One. 2023;18(6):e0287201. Published 2023 Jun 15. doi:10.1371/journal.pone.0287201.
   PubMed Web of Science ®Google Scholar
• Health Commission of Anhui Province. Guan Yu shi Si Jie Ren Da Yi Ci Hui Yi Di 0761 Hao Dai Biao Jian Yi Da Fu De Han (in Chinese). Published 2023 [accessed 2023 Sep 16]. https://wjw.ah.gov.cn/public/7001/56851441.html.
   Google Scholar
• Consulate General of the People’s Republic of China in Perth. COVID-19 Health Code NOT Required from 8 January 2023. Published 2022 [accessed 2023 Aug 20]. http://perth.china-consulate.gov.cn/eng/notc/202212/t20221230_10998616.htm.
   Google Scholar
• World Health Organization. Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic. Published 2023 [accessed 2023 Aug 20]. https://www.who.int/news/item/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic.
   Google Scholar
• World Health Organization. WHO press conference on COVID-19 and other global health issues - 5 May 2023. Published 2023 [accessed 2023 May 15]. https://www.who.int/multi-media/details/who-press-conference-on-covid-19-and-other-global-health-issues---5-may–2023.
   Google Scholar
• Xin Hua She Xin Mei Ti (in Chinese). Zhuan Jia Jie Du Xin Guan Yi Qing Bu Zai Gou Cheng “Guo Ji Guan Zhu De Tu Fa Gong Gong Wei Sheng Shi Jian” De Yuan Yin. China: Baidu; Published 2023 [accessed 2023 May 15]. https://baijiahao.baidu.com/s?id=1765316597607051421&wfr=spider&for=pc.
   Google Scholar
• Majeed B, David JF, Bragazzi NL, McCarthy Z, Grunnill MD, Heffernan J, Wu J, Woldegerima WA. Mitigating co-circulation of seasonal influenza and COVID-19 pandemic in the presence of vaccination: A mathematical modeling approach. Front Public Health. 2023;10:1086849. doi:10.3389/fpubh.2022.1086849.
   PubMed Web of Science ®Google Scholar
• Wang Q, Yue N, Zheng M, Wang D, Duan C, Yu X, Zhang X, Bao C, Jin H. Influenza vaccination coverage of population and the factors influencing influenza vaccination in mainland China: a meta-analysis. Vaccine. 2018;36(48):7262–9. doi:10.1016/j.vaccine.2018.10.045.
   PubMed Web of Science ®Google Scholar
• Sun KS, Lam TP, Kwok KW, Lam KF, Wu D, Ho PL. Seasonal influenza vaccine uptake among Chinese in Hong Kong: barriers, enablers and vaccination rates. Hum Vaccin Immunother. 2020;16(7):1675–84. doi:10.1080/21645515.2019.1709351.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Tang J, Zhang J, Wu Q. Impact of the coronavirus disease 2019 epidemic and a free influenza vaccine strategy on the willingness of residents to receive influenza vaccines in Shanghai, China. Hum Vaccin Immunother. 2021 Jul 3;17(7):2289–92. doi:10.1080/21645515.2020.1871571.
   PubMed Web of Science ®Google Scholar
• Qi D, Zhongyan W, Yu Z, Tongxin S, Xiaokun G, Xiaoshuang X, Yahui H, Lin W, Xin L. 2019 influenza vaccination in Tianjin Hexi district. Zhonghua Lao Nian Xin Nao Xue Guan Bing Za Zhi (In Chinese). 2021;23(4):391–3. doi:10.3969/j.issn.1009-0126.2021.04.015.
   Google Scholar
• Wu L, Guo X, Liu J, Ma X, Huang Z, Sun X. Evaluation of influenza vaccination coverage in Shanghai city during the 2016/17 to 2020/21 influenza seasons. Hum Vaccin Immunother. 2022;18(5):2075211. doi:10.1080/21645515.2022.2075211.
   PubMed Web of Science ®Google Scholar
• Silva J, Bratberg J, Lemay V. COVID-19 and influenza vaccine hesitancy among college students. J Am Pharm Assoc (2003). 2021;61(6):709–14.e1. doi:10.1016/j.japh.2021.05.009.
   PubMed Web of Science ®Google Scholar
• Yan Q, Xiang Z, Chunhua Q, Yiwen X, Yiping C, Lianhua W, Xiaoxiao C. Coverage levels of influenza vaccine and 23-valent pneumococcal polysaccharide vaccine among ≥60-year-old population of Taizhou city after implementation of a free vaccination policy. Zhongguo Yi Miao He Mian Yi (In Chinese). 2022;28(2):204–7+237. doi:10.19914/j.CJVI.2022040.
   Google Scholar
• Sulis G, Basta NE, Wolfson C, Kirkland SA, McMillan J, Griffith LE, Raina P. Influenza vaccination uptake among Canadian adults before and during the COVID-19 pandemic: an analysis of the Canadian longitudinal study on aging (CLSA). Vaccine. 2022;40(3):503–11. doi:10.1016/j.vaccine.2021.11.088.
   PubMed Web of Science ®Google Scholar
• An PL, Nguyen HTN, Dang HTB, Huynh QNH, Pham BDU, Huynh G. Integrating Health behavior theories to predict intention to get a COVID-19 vaccine. Health Serv Insights. 2021;14:11786329211060130. doi:10.1177/11786329211060130.
   Web of Science ®Google Scholar
• Yu Y, Ma YL, Luo S, Wang S, Zhao J, Zhang G, Li L, Li L, Tak-Fai Lau J. Prevalence and factors of influenza vaccination during the COVID-19 pandemic among university students in China. Vaccine. 2022;40(24):3298–304. doi:10.1016/j.vaccine.2022.04.077.
   PubMed Web of Science ®Google Scholar
• Sturm L, Kasting ML, Head KJ, Hartsock JA, Zimet GD. Influenza vaccination in the time of COVID-19: a national U.S. survey of adults. Vaccine. 2021;39(14):1921–8. doi:10.1016/j.vaccine.2021.03.003.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Coronavirus disease (COVID-19): similarities and differences between COVID-19 and influenza. Published 2023 [accessed 2023 Sep 1]. https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-covid-19-similarities-and-differences-with-influenza.
   Google Scholar
• Du Y, Jin C, Jit M, Chantler T, Lin L, Larson HJ, Li J, Gong W, Yang F, Ren N, et al. Influenza vaccine uptake among children and older adults in China: a secondary analysis of a quasi-experimental study. BMC Infect Dis. 2023;23(1):225. Published 2023 Apr 13. doi:10.1186/s12879-023-08145-8.
   PubMed Web of Science ®Google Scholar
• Parker AM, Atshan S, Walsh MM, Gidengil CA, Vardavas R. Association of COVID-19 vaccination with influenza vaccine history and changes in influenza vaccination. JAMA Netw Open. 2022;5(11):e2241888. doi:10.1001/jamanetworkopen.2022.41888.
   PubMed Web of Science ®Google Scholar
• Dombrádi V, Joó T, Palla G, Pollner P, Belicza É. Comparison of hesitancy between COVID-19 and seasonal influenza vaccinations within the general Hungarian population: a cross-sectional study. BMC Public Health. 2021;21(1):2317. Published 2021 Dec 23. doi:10.1186/s12889-021-12386-0.
   PubMed Web of Science ®Google Scholar
• Abu-Hammad O, Alduraidi H, Abu-Hammad S, Alnazzawi A, Babkair H, Abu-Hammad A, Nourwali I, Qasem F, Dar-Odeh N. Side effects reported by Jordanian healthcare workers who received COVID-19 vaccines. Vaccines (Basel). 2021;9(6):577. doi:10.3390/vaccines9060577.
   PubMed Web of Science ®Google Scholar
• Mulligan MJ, Lyke KE, Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil K, Raabe V, Bailey R, Swanson KA, et al. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults [published correction appears in nature. 2021 Feb;590(7844): E26]. Nature. 2020;586(7830):589–93. doi:10.1038/s41586-020-2639-4.
   PubMed Web of Science ®Google Scholar
• Walsh EE, Frenck RW Jr, Falsey AR, Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil K, Mulligan MJ, Bailey R, et al. Safety and immunogenicity of two RNA-Based covid-19 vaccine candidates. N Engl J Med. 2020;383(25):2439–50. doi:10.1056/NEJMoa2027906.
   PubMed Web of Science ®Google Scholar
• Andrzejczak-Grządko S, Czudy Z, Donderska M. Side effects after COVID-19 vaccinations among residents of Poland. Eur Rev Med Pharmacol Sci. 2021;25(12):4418–21. doi:10.26355/eurrev_202106_26153.
   PubMed Web of Science ®Google Scholar
• Leuchter RK, Jackson NJ, Mafi JN, Sarkisian CA. Association between COVID-19 vaccination and influenza vaccination rates. N Engl J Med. 2022;386(26):2531–2. doi:10.1056/NEJMc2204560.
   PubMed Web of Science ®Google Scholar
• Domnich A, Orsi A, Trombetta CS, Guarona G, Panatto D, Icardi G. COVID-19 and seasonal influenza vaccination: cross-protection, co-administration, combination vaccines, and hesitancy. Pharmaceuticals (Basel). 2022;15(3):322. doi:10.3390/ph15030322.
   PubMedGoogle Scholar
• Zhang T, Bai XF, Wang W, Liu XX, Zhang XX, Wang DY, Zhang SB, Chen ZP, He HQ, Huang ZY, et al. Consideration on implementation of co-administration of seasonal influenza and COVID-19 vaccines during pandemic in China. Zhonghua Yu Fang Yi Xue Za Zhi. 2022;56(2):103–7. doi:10.3760/cma.j.cn112150-20211203-01117.
   PubMedGoogle Scholar
• Lazarus R, Baos S, Cappel-Porter H, Carson-Stevens A, Clout M, Culliford L, Emmett SR, Garstang J, Gbadamoshi L, Hallis B, et al. Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdox1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFlucov): a multicentre, randomised, controlled, phase 4 trial. Lancet. 2021;398(10318):2277–87. doi:10.1016/S0140-6736(21)02329-1.
   PubMed Web of Science ®Google Scholar
• Toback S, Galiza E, Cosgrove C, Galloway J, Goodman AL, Swift PA, Rajaram S, Graves-Jones A, Edelman J, Burns F, et al. Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial. Lancet Respir Med. 2022;10(2):167–79. doi:10.1016/S2213-2600(21)00409-4.
   PubMed Web of Science ®Google Scholar
• UK Government. Independent report. JCVI interim advice: potential COVID-19 booster vaccine programme winter 2021 to 2022. Published 2021. [accessed 2023 Aug 27]. https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022/jcvi-interim-advice-potential-covid-19-booster-vaccine-programme-winter-2021-to-2022.
   Google Scholar
• McCauley J, Barr IG, Nolan T, Tsai T, Rockman S, Taylor B. The importance of influenza vaccination during the COVID-19 pandemic. Influenza Other Respir Viruses. 2022;16(1):3–6. doi:10.1111/irv.12917.
   PubMed Web of Science ®Google Scholar
• Xie Y, Tian X, Zhang X, Yao H, Wu N. Immune interference in effectiveness of influenza and COVID-19 vaccination. Front Immunol. 2023;14:1167214. Published 2023 Apr 19. doi:10.3389/fimmu.2023.1167214.
   PubMed Web of Science ®Google Scholar
• Shenyu W, Xiaoqian D, Bo C, Xuan D, Zeng W, Hangjie Z, Qianhui Z, Zhenzhen L, Chuanfu Y, Juan Y, et al. Immunogenicity and safety of a SARS-CoV-2 inactivated vaccine (CoronaVac) co-administered with an inactivated quadrivalent influenza vaccine: a randomized, open-label, controlled study in healthy adults aged 18 to 59 years in China. Vaccine. 2022;40(36):5356–65. doi:10.1016/j.vaccine.2022.07.021.
   PubMed Web of Science ®Google Scholar
• Li K, Yu T, Seabury SA, Dor A. Trends and disparities in the utilization of influenza vaccines among commercially insured US adults during the COVID-19 pandemic. Vaccine. 2022;40(19):2696–704. doi:10.1016/j.vaccine.2022.03.058.
   PubMed Web of Science ®Google Scholar
• Prada-García C, Fernández-Espinilla V, Hernán-García C, Sanz-Muñoz I, Martínez-Olmos J, Eiros JM, Castrodeza-Sanz J. Attitudes, perceptions and practices of influenza vaccination in the adult population: results of a cross-sectional survey in Spain. Int J Environ Res Public Health. 2022;19(17). doi:10.3390/ijerph191711139.
   PubMed Web of Science ®Google Scholar
• McElfish PA, Willis DE, Shah SK, Bryant-Moore K, Rojo MO, Selig JP. Sociodemographic determinants of COVID-19 vaccine hesitancy, fear of infection, and protection self-efficacy. J Prim Care Community Health. 2021;12:21501327211040746. doi:10.1177/21501327211040746.
   Web of Science ®Google Scholar
• Morgan R, Klein SL. The intersection of sex and gender in the treatment of influenza. Curr Opin Virol. 2019;35:35–41. doi:10.1016/j.coviro.2019.02.009.
   PubMed Web of Science ®Google Scholar
• Sánchez-de PL, Ortiz de Lejarazu-Leonardo R, Castrodeza-Sanz J, Tamayo-Gómez E, Eiros-Bouza JM, Sanz-Muñoz I. Do vaccines need a gender perspective? Influenza says yes! Front Immunol. 2021;12:715688. doi:10.3389/fimmu.2021.715688.
   PubMed Web of Science ®Google Scholar
• Ortiz JR, Yu SL, Driscoll AJ, Williams SR, Robertson J, Hsu JS, Chen WH, Biellik RJ, Sow S, Kochhar S, et al. The operational feasibility of vaccination programs targeting influenza risk groups in the World Health Organization (WHO) African and South-East Asian Regions. Clin Infect Dis. 2022;74(2):227–36. doi:10.1093/cid/ciab393.
   PubMed Web of Science ®Google Scholar